<DOC>
	<DOCNO>NCT02378038</DOCNO>
	<brief_summary>This study sponsor Sierra Oncology , Inc. formerly ProNAi Therapeutics , Inc . It multi-center , single-arm , 2-stage , open-label phase II investigation PNT2258 characterize anti-tumor activity collect safety data patient Richter 's Transformation .</brief_summary>
	<brief_title>PNT2258 Treatment Patients With Richter 's Transformation ( Brighton )</brief_title>
	<detailed_description />
	<criteria>1 . Histologically confirm Richter 's transformation ( RT ) chronic lymphocytic leukemia/small lymphocytic lymphoma ( CLL/SLL ) . 2 . Availability fresh archive tumor tissue . 3 . FDG PETCT ( disease ) positive baseline scan measurable disease . 4 . ECOG performance status 01 . 5 . Evidence disease progression study entry . 6 . Discontinuation prior anticancer therapy ≥ 7 day prior C1D1 recover ≤ CTCAE grade 2 ( baseline ) acute chronic toxicity associate prior therapy . 7 . Must previously receive least one prior chemotherapeutic regimen RT . Previously untreated RT patient deem ineligible , refuse , intensive chemotherapy eligible . 8 . Adequate bone marrow , renal , hepatic function . 9 . Normal Coagulation profile . 10 . Agreement use acceptable method contraception study ≥ 120 day last dose PNT2258 sexually active able bear beget child . 11 . Ability participate clinical study minimum least 2 cycle ( 6 week ) . 1 . Concurrent nonhematologic malignancy require treatment . 2 . No 2 prior regimen DLBCL . 3 . Hodgkin 's variant Richter 's lymphoma , accelerate CLL , composite lymphoma , interdigitating dendritic cell sarcoma , sarcoma , EBVassociated lymphoma prolymphocytic transformation . 4 . Ongoing risk bleeding . 5 . CNS leptomeningeal involvement lymphoma 6 . Concurrent clinically significant illness , medical condition , surgical history , physical finding , electrocardiogram laboratory finding , opinion investigator , could adversely affect safety subject impair assessment study result . 7 . Pregnancy breastfeed . 8 . Previous exposure PNT2258 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>PNT2258</keyword>
	<keyword>Richter 's Transformation</keyword>
	<keyword>NHL</keyword>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>DLBCL</keyword>
	<keyword>Diffuse Large B-cell Lymphoma</keyword>
	<keyword>Lymphoma , Large B-cell , Diffuse</keyword>
	<keyword>Lymphoma , Non-Hodgkin</keyword>
	<keyword>Lymphoma , B-cell</keyword>
</DOC>